▶주메뉴 바로가기

▶본문 바로가기

The Korea Herald
검색폼

THE INVESTOR
April 27, 2024

Stocks & Bonds

[STOCK WATCH] Boryung Pharmaceutical falls 5.42%

  • PUBLISHED :October 27, 2017 - 11:39
  • UPDATED :October 27, 2017 - 11:39
  • 폰트작게
  • 폰트크게
  • facebook
  • sms
  • print
[THE INVESTOR] As of Oct. 27 11:25 A.M., Boryung Pharmaceutical declined 5.42%, compared with yesterday, to 39,300 won. It had edged along with a similar price through the past month. Standard deviation, which indicates risk, records 1.7% over the same period over one month.

Compared with its close competitors within the same industry, KOSPI, as the monthly volatility of Boryung Pharmaceutical was at a low level, the earnings rate for 1 month was also relatively lower than that of its peer group. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was 0.1%. Even though the volatility was not so high, the return-on-risk was low through a decline in investment returns. Moreover, compared with the KOSPI industry, the return-on-risk is below the industrial mean, 5.6, and thus it is hard to say that the industrial comparison performance was positive.

By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.

EDITOR'S PICKS